Sundrug Co.,Ltd.

Tokyo Stock Exchange 9989.T

Sundrug Co.,Ltd. Revenue for the year ending March 31, 2024: USD 4.97 B

Sundrug Co.,Ltd. Revenue is USD 4.97 B for the year ending March 31, 2024, a -4.43% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.

Sundrug Co.,Ltd. Revenue for the year ending March 31, 2023 was USD 5.20 B, a -2.48% change year over year.
Sundrug Co.,Ltd. Revenue for the year ending March 31, 2022 was USD 5.33 B, a -6.96% change year over year.
Sundrug Co.,Ltd. Revenue for the year ending March 31, 2021 was USD 5.73 B, a -0.29% change year over year.
Sundrug Co.,Ltd. Revenue for the year ending March 31, 2020 was USD 5.74 B, a 8.31% change year over year.

Key data

Date	Revenue	Gross Profit	Operating Income	EBIT

Tokyo Stock Exchange: 9989.T

Sundrug Co.,Ltd.

CEO	Mr. Hiroshi Sadakata
IPO Date	Jan. 4, 2001
Location	Japan
Headquarters	1-38-1, Wakamatsucho
Employees	6,662
Sector	Health Care
Industries Drugstores & Retail Pharmacies Discount Retailers Retail & Wholesale

Description

Sundrug Co.,Ltd. operates and manages drug stores and dispensing pharmacies in Japan. It also operates discount stores that offers food, cosmetics, home appliances, clothing, car supplies, sports and goods, alcoholic beverages, and pharmaceutical products, as well as fresh food, kerosene, etc. The company was founded in 1957 and is headquartered in Fuchu, Japan.

Key trends

Past 5 years